<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Curis Inc. | Company News & Executive Profiles - CRIS | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/curis+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Curis Inc.]]></description>
	<s:counts start="0" returned="10" found="11" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Curis' Cancer Therapy Arouses Curiosity]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F160141-curis-cancer-therapy-arouses-curiosity%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Kris Tuttle submits:   It&#8217;s nearly impossible these days not to be personally touched by cancer. The disease has to be on the top of everyone&#8217;s list for finding new, more effective treatments.   Putting our personal feelings aside for the moment, we also recognize that any company...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Sun, 06 Sep 2009 03:18:35 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/kris+tuttle.html"><![CDATA[Kris Tuttle]]></category>
		<category domain="http://resources.bnet.com/topic/curis+inc..html"><![CDATA[Curis Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CRIS</category>
		<category domain="tickers">CRIS</category>
	</item>
	<item>
		<title><![CDATA[Curis: The Wall Street Analyst Forum Presentation Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-233055.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionUnidentified Audience Member  Does that $30 million reflect the 14?  Daniel Passeri  No.  Unidentified Audience Member  Or is it 45 or the 30?  Daniel Passeri  No. It was 30 prior to raising the 14. Any other questions?  Unidentified Audience Member...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 20 Sep 2007 15:58:13 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/curis+inc..html"><![CDATA[Curis Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CRIS</category>
		<category domain="tickers">CRIS</category>
	</item>
	<item>
		<title><![CDATA[Homeland Security Market Continues to Demonstrate Strong Growth.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200704/ai_n19719171]]></link>
		<description><![CDATA[M2 PRESSWIRE-26 April 2007-GrowthStockAnalyst.com: Homeland  Security Market Continues to Demonstrate Strong GrowthC1994-2007 M2  COMMUNICATIONS LTD    RDATE:26042007    Stocks to Watch: VIASPACE Inc. (OTCBB: VSPC), i-level Media Group  (OTC BB:ILVL), Curis, Inc. (Nasdaq:CRIS), Chapeau, Inc (OTC BB:CPEU),  Vonage Holdings Corporation (NYSE:VG) ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 26 Apr 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/chapeau+inc..html"><![CDATA[Chapeau Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/curis+inc..html"><![CDATA[Curis Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/nasa.html"><![CDATA[NASA]]></category>
		<category domain="http://resources.bnet.com/topic/phone.html"><![CDATA[phone]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[SECURITY]]></category>
		<category domain="http://resources.bnet.com/topic/viaspace+inc..html"><![CDATA[Viaspace Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/vonage+holdings+corp..html"><![CDATA[Vonage Holdings Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CPEU</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CRIS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VSPC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VG</category>
		<category domain="tickers">CPEU,CRIS,VSPC,VG</category>
	</item>
	<item>
		<title><![CDATA[MASS Opportunities: A Biotechnology Investment Conference Presenter Profiles]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_Nov_2/ai_n15772166]]></link>
		<description><![CDATA[BOSTON -- MASS Opportunities: A Biotechnology Investment Conference takes place Nov. 3 at the Logan Airport Hilton in Boston. For in-depth information about the event visit http://www.massbio.org/events/mass_opps/.  Below are profiles from MASS Opportunities: A Biotechnology Investment Conference presenters; breaking news releases are available at http://www.tradeshownews.com, Business Wire's trade show,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 02 Nov 2005 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/acusphere+inc..html"><![CDATA[Acusphere Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/arqule+inc..html"><![CDATA[ArQule Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[compound]]></category>
		<category domain="http://resources.bnet.com/topic/curis+inc..html"><![CDATA[Curis Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/e-mail.html"><![CDATA[E-mail]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[MARKETING]]></category>
		<category domain="http://resources.bnet.com/topic/media.html"><![CDATA[Media]]></category>
		<category domain="http://resources.bnet.com/topic/metabolix+inc..html"><![CDATA[Metabolix Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/momenta+pharmaceuticals+inc..html"><![CDATA[Momenta Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/oxigene+inc..html"><![CDATA[Oxigene Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/phone.html"><![CDATA[phone]]></category>
		<category domain="http://resources.bnet.com/topic/studies.html"><![CDATA[STUDIES]]></category>
		<category domain="http://resources.bnet.com/topic/synta+pharmaceuticals+corp..html"><![CDATA[Synta Pharmaceuticals Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/technology.html"><![CDATA[technology]]></category>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/web.html"><![CDATA[Web]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ACUS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ARQL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CRIS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MBLX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MNTA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">OXGN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SNTA</category>
		<category domain="tickers">ACUS,ARQL,CRIS,MBLX,MNTA,NDAQ,OXGN,SNTA</category>
	</item>
	<item>
		<title><![CDATA[Curis to Present at the 2005 Bear Stearns Healthcare Conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_Sept_1/ai_n15336227]]></link>
		<description><![CDATA[CAMBRIDGE, Mass. -- Headline should read: Curis to Present at the 2005 Bear Stearns Healthcare Conference sted Curis to Present at the Bear Stearns Boston Biotech Confab  The corrected release reads:  CURIS TO PRESENT AT THE 2005 BEAR STEARNS HEALTHCARE CONFERENCE  Curis, Inc. (NASDAQ: CRIS), a therapeutic...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 01 Sep 2005 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/bear+stearns+%2526+co.+inc..html"><![CDATA[Bear Stearns & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/conference.html"><![CDATA[conference]]></category>
		<category domain="http://resources.bnet.com/topic/curis+inc..html"><![CDATA[Curis Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[SOFTWARE]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CRIS</category>
		<category domain="tickers">CRIS</category>
	</item>
	<item>
		<title><![CDATA[Curis Issued U.S. Patent Covering Method for Treating Stroke]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2004_July_29/ai_n6131527]]></link>
		<description><![CDATA[CAMBRIDGE, Mass. -- Patent part of technology portfolio licensed to Wyeth Pharmaceuticals for multiple therapeutic applications  Curis, Inc. (NASDAQ: CRIS), a therapeutic drug development company, today announced that it was issued U.S. patent 6,767,888, entitled "Neuroprotective methods and reagents." The claims of this patent recite methods for treatment with...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 29 Jul 2004 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/curis+inc..html"><![CDATA[Curis Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/wyeth+pharmaceuticals+inc..html"><![CDATA[Wyeth Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CRIS</category>
		<category domain="tickers">CRIS</category>
	</item>
	<item>
		<title><![CDATA[Curis Reports First Quarter 2004 Results]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2004_April_28/ai_n6002287]]></link>
		<description><![CDATA[Business Editors  CAMBRIDGE, Mass.--BUSINESS WIRE--April 28, 2004  Curis, Inc. (Nasdaq:CRIS), a therapeutic drug development company, today reported its financial results for the first quarter ended March 31, 2004.  For the first quarter of 2004, the Company reported a net loss applicable to common stockholders of $4,038,000 or...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 28 Apr 2004 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/curis+inc..html"><![CDATA[Curis Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/genentech+inc..html"><![CDATA[Genentech Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/wyeth+pharmaceuticals+inc..html"><![CDATA[Wyeth Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CRIS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
		<category domain="tickers">CRIS,DNA</category>
	</item>
	<item>
		<title><![CDATA[Curis Reports Third Quarter Fiscal 2000 Results]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2000_Nov_14/ai_66940515]]></link>
		<description><![CDATA[Attention Business and Science Editors  CAMBRIDGE, Mass.--BUSINESS WIRE-- Nov. 14, 2000  Curis, Inc. (NASDAQ:CRIS) today reported the results of its operations for the three- and nine-month periods ended September 30, 2000. These results include combined results of the three companies merged into Curis as described below.  On...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 14 Nov 2000 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/amortization.html"><![CDATA[amortization]]></category>
		<category domain="http://resources.bnet.com/topic/asset.html"><![CDATA[asset]]></category>
		<category domain="http://resources.bnet.com/topic/cell.html"><![CDATA[cell]]></category>
		<category domain="http://resources.bnet.com/topic/curis+inc..html"><![CDATA[Curis Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/dr..html"><![CDATA[Dr.]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/merger.html"><![CDATA[merger]]></category>
		<category domain="http://resources.bnet.com/topic/nist.html"><![CDATA[NIST]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CRIS</category>
		<category domain="tickers">CRIS</category>
	</item>
	<item>
		<title><![CDATA[CURIS INC.(trading on Nasdaq)(Brief Article)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_200008/ai_n13311497]]></link>
		<description><![CDATA[CURIS Inc., a new biopharmaceutical company formed from the merger  of Creative BioMolecules, Ontogeny Inc. and Reprogenesis Inc., began  trading on the Nasdag last week following shareholder approval of the  merger.   ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 07 Aug 2000 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/curis+inc..html"><![CDATA[Curis Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/merger.html"><![CDATA[merger]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CRIS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">CRIS,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Shareholders Approve Curis, Inc. Merger of Three Biotechnology Companies]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2000_July_31/ai_63754883]]></link>
		<description><![CDATA[Attention Business and Science Editors  CAMBRIDGE, Mass.--BUSINESS WIRE--July 31, 2000  Curis (Nasdaq: CRIS) to Begin Trading August 1, 2000,  Creative BioMolecules (Nasdaq: CBMI) to Stop  Trading 4pm July 31, 2000  A new biopharmaceutical company focused on regenerative medicine, Curis, Inc., began operations today following the...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 31 Jul 2000 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/curis+inc..html"><![CDATA[Curis Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/merger.html"><![CDATA[merger]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/shareholder.html"><![CDATA[shareholder]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CRIS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">CRIS,NDAQ</category>
	</item>
</channel>
</rss>
